Showing results (331-340 of 2,224) with videos related to
Sort By:
Pageof 223
Handbook of Experimental Pharmacology|December 20, 2014
Regulation of HDL genes: transcriptional, posttranscriptional, and posttranslationalDimitris Kardassis, Anca Gafencu, Vassilis I Zannis, et al.Handbook of Experimental Pharmacology|December 20, 2014
Beyond the genetics of HDL: why is HDL cholesterol inversely related to cardiovascular disease?J A Kuivenhoven, A K GroenHandbook of Experimental Pharmacology|December 20, 2014
Mouse models of disturbed HDL metabolismMenno Hoekstra, Miranda Van EckHandbook of Experimental Pharmacology|December 20, 2014
Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functionsFabrizio Montecucco, Elda Favari, Giuseppe Danilo Norata, et al.Handbook of Experimental Pharmacology|December 20, 2014
Therapeutic potential of HDL in cardioprotection and tissue repairSophie Van Linthout, Miguel Frias, Neha Singh, et al.Handbook of Experimental Pharmacology|December 20, 2014
Emerging small molecule drugsSophie Colin, Giulia Chinetti-Gbaguidi, Jan A Kuivenhoven, et al.Handbook of Experimental Pharmacology|September 5, 2020
Structural and Metabolic Assessment of BoneRadhika R Narla, Susan M OttHandbook of Experimental Pharmacology|September 7, 2020
How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug DevelopmentMonika Schäfer-Korting, Christian ZoschkeHandbook of Experimental Pharmacology|November 3, 2020
Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor PharmacologyTarsis F BrustHandbook of Experimental Pharmacology|November 4, 2020
Molecular Genetics of Kappa Opioids in Pain and Itch SensationsPang-Yen Tseng, Mark A HoonPageof 223